BioCardia
BCDA
16 hedge funds and large institutions have $710K invested in BioCardia in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 8 closing their positions.
3,667% more call options, than puts
Call options by funds: $113K | Put options by funds: $3K
0.03% less ownership
Funds ownership: 0.54% → 0.51% (-0.03%)
30% less funds holding
Funds holding: 23 → 16 (-7)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
84% less capital invested
Capital invested by funds: $4.43M → $710K (-$3.72M)
88% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$288K |
| 2 |
HF
HRT Financial
New York
|
+$11.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
-$344K |
| 2 |
Vontobel Holding
Zurich,
Switzerland
|
-$82.1K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$53.7K |
| 4 |
Bank of New York Mellon
New York
|
-$33.6K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$32.1K |
BCDA Hedge Fund Activity: Q3 2023 in Review
16 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q3 2023, worth a combined $710K — down 84% from $4.43M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BCDA and 1 opened new positions — a net loss of 7 holders — while 5 trimmed existing stakes and 1 added.
The largest buyer was CM Management, adding an estimated $288K. The largest seller was Lynwood Capital Management, exiting entirely with an estimated $344K sold.
- 16 institutional investors held BioCardia (BCDA) as of Q3 2023, down from 23 in Q2 2023.
- Funds reported $710K of BioCardia stock for Q3 2023, down 84% quarter-over-quarter.
- 1 fund opened new BioCardia positions in Q3 2023 and 8 closed out, a net change of -7 holders.
- The largest BioCardia buyer in Q3 2023 was CM Management, an estimated $288K added.
- The largest BioCardia seller in Q3 2023 was Lynwood Capital Management, an estimated $344K sold.
Based on aggregated 13F filings for Q3 2023.